HYTN Innovations Acquires Prism Labs To Boost Psychedelic Drug Manufacturing Capabilities
HYTN Innovations Inc. completes the acquisition of Prism Scientific Labs, enhancing its psychedelic compound manufacturing capabilities and expanding its research and development potential.
